Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immuto Scientific is a biotechnology service provider and contract research organization specializing in advanced protein characterization to accelerate drug discovery. The company utilizes its proprietary Plasma-Induced Modification of Biomolecules (PLIMB) platform to conduct high-resolution protein footprinting coupled with mass spectrometry. This technology allows for the detailed structural analysis of proteins in their native environments, providing critical data on protein-drug interactions, epitope mapping, and binding affinity. Their services are particularly valuable for challenging targets such as membrane proteins and large multi-protein complexes that are difficult to analyze using traditional structural biology methods. By offering rapid and precise structural insights, Immuto Scientific supports pharmaceutical and biotech partners in lead optimization and candidate selection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immuto Scientific.